Cancer Biomarkers - Global Market Outlook (2016-2022)
According to Stratistics MRC, the Global Cancer Biomarkers market is estimated at $9215.32 million in 2015 and is expected to reach $20958.63 million by 2022 growing at a CAGR of 12.5% from 2015 to 2022. Technological improvements, huge investment flow for Research and Development and increasing usage in drug development and drug delivery are the factors driving the market growth. On the other hand, Sample collection and storage issue and poor reimbursement policies are hampering the market. Growing awareness for personalized medication is the opportunity for the market growth.
North America captured huge share in terms of revenue owing to raising awareness towards cancer diagnostics. However, Asia Pacific is anticipated to be the fastest growing region with highest CAGR during forecast period, because of increasing demand for non invasive diagnosis in this region. The diagnostics segment holds largest share in the market, followed by drug discovery and development.
Some of the key players in the market include Abbott Laboratories, Becton Dickinson and Company, Correlogic Systems, Inc., Agilent Technologies, Biomerieux S.A., Astellas Pharma US Inc., Roche Diagnostics Corp., Astex Pharmaceuticals, Agendia Bv, Diadexus, Inc., Ambrilia Biopharma, CuraGen, Gen-Probe Inc, Beckman Coulter, Inc., Clarient, Inc, Biocurex Inc., and Aureon Laboratories, Inc.,Services Covered:
North America captured huge share in terms of revenue owing to raising awareness towards cancer diagnostics. However, Asia Pacific is anticipated to be the fastest growing region with highest CAGR during forecast period, because of increasing demand for non invasive diagnosis in this region. The diagnostics segment holds largest share in the market, followed by drug discovery and development.
Some of the key players in the market include Abbott Laboratories, Becton Dickinson and Company, Correlogic Systems, Inc., Agilent Technologies, Biomerieux S.A., Astellas Pharma US Inc., Roche Diagnostics Corp., Astex Pharmaceuticals, Agendia Bv, Diadexus, Inc., Ambrilia Biopharma, CuraGen, Gen-Probe Inc, Beckman Coulter, Inc., Clarient, Inc, Biocurex Inc., and Aureon Laboratories, Inc.,Services Covered:
- Biomakers validation and testing
- Sample preparation
- Assay development
Diseases Covered:- Lung Cancer
- Cervical Cancer
- Prostate Cancer
- Colorectal Cancer
- Breast Cancer
- Other Cancers
- Omics Technologies
- Transcriptomics
- Proteomics
- Protein Microarray Technology
- Peptide Array Technology
- 2-D Gel Electrophoresis
- Mass Spectrometry
- Imaging Mass Spectrometry
- Maldi Mass Spectrometry
- Antibody Array Technology
- Genomics
- Microarrays
- Next Generation Sequencing (NGS)
- PCR (Polymer Chain Reaction)
- Pharmacogenomics
- Metabolomics
- Bioinformatics
- IVD multivariate index assays
- Cytogenetics
- DNA microarrays
- Ish (In Situ Hybridization)
- Immunoassays
- Flow Cytometry
- Elisa
- Immunohistochemistry (IHC)
- Imaging Technologies
- Mammography
- Ultrasound
- Magnetic Resonance Imaging (MRI)
- Computed Tomography (CT)
- Positron Emission Tomography (PET)
- Risk Assessment
- Drug Discovery and Development
- Drug formulation
- Diagnostics
- Prognostics
- Other Applications
- Genetic Biomarkers
- Protein Biomarkers
- Other Types
- Carbohydrate biomarkers
- Cell biomarkers
- Viral biomarkers
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- France
- Italy
- UK
- Spain
- Rest of Europe
- Asia Pacific
- Japan
- China
- India
- Australia
- New Zealand
- Rest of Asia Pacific
- Rest of the World
- Middle East
- Brazil
- Argentina
- South Africa
- Egypt
- Market share assessments for the regional and country level segments
- Market share analysis of the top industry players
- Strategic recommendations for the new entrants
- Market forecasts for a minimum of 7 years of all the mentioned segments, sub segments and the regional markets
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements
1 EXECUTIVE SUMMARY
2 PREFACE
2.1 Abstract
2.2 Stake Holders
2.3 Research Scope
2.4 Research Methodology
2.4.1 Data Mining
2.4.2 Data Analysis
2.4.3 Data Validation
2.4.4 Research Approach
2.5 Research Sources
2.5.1 Primary Research Sources
2.5.2 Secondary Research Sources
2.5.3 Assumptions
3 MARKET TREND ANALYSIS
3.1 Introduction
3.2 Drivers
3.3 Restraints
3.4 Opportunities
3.5 Threats
3.6 Application Analysis
3.8 Emerging Markets
4 PORTERS FIVE FORCE ANALYSIS
4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry
5 GLOBAL CANCER BIOMARKERS MARKET, BY SERVICE
5.1 Introduction
5.2 Biomakers validation and testing
5.3 Sample preparation
5.4 Assay development
6 GLOBAL CANCER BIOMARKERS MARKET, BY DISEASE
6.1 Introduction
6.2 Lung Cancer
6.3 Cervical Cancer
6.4 Prostate Cancer
6.5 Colorectal Cancer
6.6 Breast Cancer
6.7 Other Cancers
7 GLOBAL CANCER BIOMARKERS MARKET, BY PROFILING TECHNOLOGIES
7.1 Introduction
7.2 Omics Technologies
7.2.1 Transcriptomics
7.2.2 Proteomics
7.2.2.1 Protein Microarray Technology
7.2.2.2 Peptide Array Technology
7.2.2.3 2-D Gel Electrophoresis
7.2.2.4 Mass Spectrometry
7.2.2.4.1 Imaging Mass Spectrometry
7.2.2.4.2 Maldi Mass Spectrometry
7.2.2.5 Antibody Array Technology
7.2.3 Genomics
7.2.3.1 Microarrays
7.2.3.2 Next Generation Sequencing (NGS)
7.2.3.3 PCR (Polymer Chain Reaction)
7.2.4 Pharmacogenomics
7.2.5 Metabolomics
7.3 Bioinformatics
7.4 IVD multivariate index assays
7.5 Cytogenetics
7.5.1 DNA microarrays
7.5.2 Ish (In Situ Hybridization)
7.6 Immunoassays
7.6.1 Flow Cytometry
7.6.2 Elisa
7.6.3 Immunohistochemistry (IHC)
7.7 Imaging Technologies
7.7.1 Mammography
7.7.2 Ultrasound
7.7.3 Magnetic Resonance Imaging (MRI)
7.7.4 Computed Tomography (CT)
7.7.5 Positron Emission Tomography (PET)
8 GLOBAL CANCER BIOMARKERS MARKET, BY APPLICATION
8.1 Introduction
8.2 Risk Assessment
8.3 Drug Discovery and Development
8.4 Drug formulation
8.5 Diagnostics
8.6 Prognostics
8.7 Other Applications
9 GLOBAL CANCER BIOMARKERS MARKET, BY TYPE
9.1 Introduction
9.2 Genetic Biomarkers
9.3 Protein Biomarkers
9.4 Other Types
9.4.1 Carbohydrate biomarkers
9.4.2 Cell biomarkers
9.4.3 Viral biomarkers
10 GLOBAL CANCER BIOMARKERS MARKET, BY GEOGRAPHY
10.1 North America
10.1.1 US
10.1.2 Canada
10.1.3 Mexico
10.2 Europe
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 UK
10.2.5 Spain
10.2.6 Rest of Europe
10.3 Asia Pacific
10.3.1 Japan
10.3.2 China
10.3.3 India
10.3.4 Australia
10.3.5 New Zealand
10.3.6 Rest of Asia Pacific
10.4 Rest of the World
10.4.1 Middle East
10.4.2 Brazil
10.4.3 Argentina
10.4.4 South Africa
10.4.5 Egypt
11 KEY DEVELOPMENTS
11.1 Agreements, Partnerships, Collaborations and Joint Ventures
11.2 Acquisitions & Mergers
11.3 New Product Launch
11.4 Expansions
11.5 Other Key Strategies
12 COMPANY PROFILING
12.1 Abbott Laboratories,
12.2 Becton Dickinson and Company
12.3 Correlogic Systems, Inc.,
12.4 Agilent Technologies
12.5 Biomerieux S.A.,
12.6 Astellas Pharma US Inc.,
12.7 Roche Diagnostics Corp.
12.8 Astex Pharmaceuticals
12.9 Agendia Bv,
12.10 Diadexus, Inc.,
12.11 Ambrilia Biopharma,
12.12 CuraGen
12.13 Gen-Probe Inc
12.14 Beckman Coulter, Inc.,
12.15 Clarient, Inc,
12.16 Biocurex Inc.,
12.17 Aureon Laboratories, Inc.,
2 PREFACE
2.1 Abstract
2.2 Stake Holders
2.3 Research Scope
2.4 Research Methodology
2.4.1 Data Mining
2.4.2 Data Analysis
2.4.3 Data Validation
2.4.4 Research Approach
2.5 Research Sources
2.5.1 Primary Research Sources
2.5.2 Secondary Research Sources
2.5.3 Assumptions
3 MARKET TREND ANALYSIS
3.1 Introduction
3.2 Drivers
3.3 Restraints
3.4 Opportunities
3.5 Threats
3.6 Application Analysis
3.8 Emerging Markets
4 PORTERS FIVE FORCE ANALYSIS
4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry
5 GLOBAL CANCER BIOMARKERS MARKET, BY SERVICE
5.1 Introduction
5.2 Biomakers validation and testing
5.3 Sample preparation
5.4 Assay development
6 GLOBAL CANCER BIOMARKERS MARKET, BY DISEASE
6.1 Introduction
6.2 Lung Cancer
6.3 Cervical Cancer
6.4 Prostate Cancer
6.5 Colorectal Cancer
6.6 Breast Cancer
6.7 Other Cancers
7 GLOBAL CANCER BIOMARKERS MARKET, BY PROFILING TECHNOLOGIES
7.1 Introduction
7.2 Omics Technologies
7.2.1 Transcriptomics
7.2.2 Proteomics
7.2.2.1 Protein Microarray Technology
7.2.2.2 Peptide Array Technology
7.2.2.3 2-D Gel Electrophoresis
7.2.2.4 Mass Spectrometry
7.2.2.4.1 Imaging Mass Spectrometry
7.2.2.4.2 Maldi Mass Spectrometry
7.2.2.5 Antibody Array Technology
7.2.3 Genomics
7.2.3.1 Microarrays
7.2.3.2 Next Generation Sequencing (NGS)
7.2.3.3 PCR (Polymer Chain Reaction)
7.2.4 Pharmacogenomics
7.2.5 Metabolomics
7.3 Bioinformatics
7.4 IVD multivariate index assays
7.5 Cytogenetics
7.5.1 DNA microarrays
7.5.2 Ish (In Situ Hybridization)
7.6 Immunoassays
7.6.1 Flow Cytometry
7.6.2 Elisa
7.6.3 Immunohistochemistry (IHC)
7.7 Imaging Technologies
7.7.1 Mammography
7.7.2 Ultrasound
7.7.3 Magnetic Resonance Imaging (MRI)
7.7.4 Computed Tomography (CT)
7.7.5 Positron Emission Tomography (PET)
8 GLOBAL CANCER BIOMARKERS MARKET, BY APPLICATION
8.1 Introduction
8.2 Risk Assessment
8.3 Drug Discovery and Development
8.4 Drug formulation
8.5 Diagnostics
8.6 Prognostics
8.7 Other Applications
9 GLOBAL CANCER BIOMARKERS MARKET, BY TYPE
9.1 Introduction
9.2 Genetic Biomarkers
9.3 Protein Biomarkers
9.4 Other Types
9.4.1 Carbohydrate biomarkers
9.4.2 Cell biomarkers
9.4.3 Viral biomarkers
10 GLOBAL CANCER BIOMARKERS MARKET, BY GEOGRAPHY
10.1 North America
10.1.1 US
10.1.2 Canada
10.1.3 Mexico
10.2 Europe
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 UK
10.2.5 Spain
10.2.6 Rest of Europe
10.3 Asia Pacific
10.3.1 Japan
10.3.2 China
10.3.3 India
10.3.4 Australia
10.3.5 New Zealand
10.3.6 Rest of Asia Pacific
10.4 Rest of the World
10.4.1 Middle East
10.4.2 Brazil
10.4.3 Argentina
10.4.4 South Africa
10.4.5 Egypt
11 KEY DEVELOPMENTS
11.1 Agreements, Partnerships, Collaborations and Joint Ventures
11.2 Acquisitions & Mergers
11.3 New Product Launch
11.4 Expansions
11.5 Other Key Strategies
12 COMPANY PROFILING
12.1 Abbott Laboratories,
12.2 Becton Dickinson and Company
12.3 Correlogic Systems, Inc.,
12.4 Agilent Technologies
12.5 Biomerieux S.A.,
12.6 Astellas Pharma US Inc.,
12.7 Roche Diagnostics Corp.
12.8 Astex Pharmaceuticals
12.9 Agendia Bv,
12.10 Diadexus, Inc.,
12.11 Ambrilia Biopharma,
12.12 CuraGen
12.13 Gen-Probe Inc
12.14 Beckman Coulter, Inc.,
12.15 Clarient, Inc,
12.16 Biocurex Inc.,
12.17 Aureon Laboratories, Inc.,
LIST OF TABLES
1 Global Cancer Biomarkers Market Outlook, By Region (2013-2022) ($MN)
2 Global Cancer Biomarkers Market Outlook, By Service (2013-2022) ($MN)
3 Global Cancer Biomarkers Market Outlook, By Biomakers validation and testing (2013-2022) ($MN)
4 Global Cancer Biomarkers Market Outlook, By Sample preparation (2013-2022) ($MN)
5 Global Cancer Biomarkers Market Outlook, By Assay developement (2013-2022) ($MN)
6 Global Cancer Biomarkers Market Outlook, By Disease (2013-2022) ($MN)
7 Global Cancer Biomarkers Market Outlook, By Lung Cancer (2013-2022) ($MN)
8 Global Cancer Biomarkers Market Outlook, By Cervical Cancer (2013-2022) ($MN)
9 Global Cancer Biomarkers Market Outlook, By Prostate Cancer (2013-2022) ($MN)
10 Global Cancer Biomarkers Market Outlook, By Colorectal Cancer (2013-2022) ($MN)
11 Global Cancer Biomarkers Market Outlook, By Breast Cancer (2013-2022) ($MN)
12 Global Cancer Biomarkers Market Outlook, By Other Cancers (2013-2022) ($MN)
13 Global Cancer Biomarkers Market Outlook, By Profiling Technologies (2013-2022) ($MN)
14 Global Cancer Biomarkers Market Outlook, By Omics Technologies (2013-2022) ($MN)
15 Global Cancer Biomarkers Market Outlook, By Transcriptomics (2013-2022) ($MN)
16 Global Cancer Biomarkers Market Outlook, By Proteomics (2013-2022) ($MN)
17 Global Cancer Biomarkers Market Outlook, By Protein Microarray Technology (2013-2022) ($MN)
18 Global Cancer Biomarkers Market Outlook, By Peptide Array Technology (2013-2022) ($MN)
19 Global Cancer Biomarkers Market Outlook, By 2-D Gel Electrophoresis (2013-2022) ($MN)
20 Global Cancer Biomarkers Market Outlook, By Mass Spectrometry (2013-2022) ($MN)
21 Global Cancer Biomarkers Market Outlook, By Imaging Mass Spectrometry (2013-2022) ($MN)
22 Global Cancer Biomarkers Market Outlook, By Maldi Mass Spectrometry (2013-2022) ($MN)
23 Global Cancer Biomarkers Market Outlook, By Antibody Array Technology (2013-2022) ($MN)
24 Global Cancer Biomarkers Market Outlook, By Genomics (2013-2022) ($MN)
25 Global Cancer Biomarkers Market Outlook, By Microarrays (2013-2022) ($MN)
26 Global Cancer Biomarkers Market Outlook, By Next Generation Sequencing (NGS) (2013-2022) ($MN)
27 Global Cancer Biomarkers Market Outlook, By PCR (Polymer Chain Reaction) (2013-2022) ($MN)
28 Global Cancer Biomarkers Market Outlook, By Pharmacogenomics (2013-2022) ($MN)
29 Global Cancer Biomarkers Market Outlook, By Metabolomics (2013-2022) ($MN)
30 Global Cancer Biomarkers Market Outlook, By Bioinformatics (2013-2022) ($MN)
31 Global Cancer Biomarkers Market Outlook, By IVD multivariate index assays (2013-2022) ($MN)
32 Global Cancer Biomarkers Market Outlook, By Cytogenetics (2013-2022) ($MN)
33 Global Cancer Biomarkers Market Outlook, By DNA microarrays (2013-2022) ($MN)
34 Global Cancer Biomarkers Market Outlook, By Ish (In Situ Hybridization) (2013-2022) ($MN)
35 Global Cancer Biomarkers Market Outlook, By Immunoassays (2013-2022) ($MN)
36 Global Cancer Biomarkers Market Outlook, By Flow Cytometry (2013-2022) ($MN)
37 Global Cancer Biomarkers Market Outlook, By Elisa (2013-2022) ($MN)
38 Global Cancer Biomarkers Market Outlook, By Immunohistochemistry (IHC) (2013-2022) ($MN)
39 Global Cancer Biomarkers Market Outlook, By Imaging Technologies (2013-2022) ($MN)
40 Global Cancer Biomarkers Market Outlook, By Mammography (2013-2022) ($MN)
41 Global Cancer Biomarkers Market Outlook, By Ultrasound (2013-2022) ($MN)
42 Global Cancer Biomarkers Market Outlook, By Magnetic Resonance Imaging (MRI) (2013-2022) ($MN)
43 Global Cancer Biomarkers Market Outlook, By Computed Tomography (CT) (2013-2022) ($MN)
44 Global Cancer Biomarkers Market Outlook, By Positron Emission Tomography (PET) (2013-2022) ($MN)
45 Global Cancer Biomarkers Market Outlook, By Application (2013-2022) ($MN)
46 Global Cancer Biomarkers Market Outlook, By Risk Assessment (2013-2022) ($MN)
47 Global Cancer Biomarkers Market Outlook, By Drug Discovery and Development (2013-2022) ($MN)
48 Global Cancer Biomarkers Market Outlook, By Drug formulation (2013-2022) ($MN)
49 Global Cancer Biomarkers Market Outlook, By Diagnostics (2013-2022) ($MN)
50 Global Cancer Biomarkers Market Outlook, By Prognostics (2013-2022) ($MN)
51 Global Cancer Biomarkers Market Outlook, By Other Applications (2013-2022) ($MN)
52 Global Cancer Biomarkers Market Outlook, By Type (2013-2022) ($MN)
53 Global Cancer Biomarkers Market Outlook, By Genetic Biomarkers (2013-2022) ($MN)
54 Global Cancer Biomarkers Market Outlook, By Protein Biomarkers (2013-2022) ($MN)
55 Global Cancer Biomarkers Market Outlook, By Other Types (2013-2022) ($MN)
56 Global Cancer Biomarkers Market Outlook, By Carbohydrate biomarkers (2013-2022) ($MN)
57 Global Cancer Biomarkers Market Outlook, By Cell biomarkers (2013-2022) ($MN)
58 Global Cancer Biomarkers Market Outlook, By Viral biomarkers (2013-2022) ($MN)
59 North America Cancer Biomarkers Market Outlook, By Country (2013-2022) ($MN)
60 North America Cancer Biomarkers Market Outlook, By Service (2013-2022) ($MN)
61 North America Cancer Biomarkers Market Outlook, By Biomakers validation and testing (2013-2022) ($MN)
62 North America Cancer Biomarkers Market Outlook, By Sample preparation (2013-2022) ($MN)
63 North America Cancer Biomarkers Market Outlook, By Assay developement (2013-2022) ($MN)
64 North America Cancer Biomarkers Market Outlook, By Disease (2013-2022) ($MN)
65 North America Cancer Biomarkers Market Outlook, By Lung Cancer (2013-2022) ($MN)
66 North America Cancer Biomarkers Market Outlook, By Cervical Cancer (2013-2022) ($MN)
67 North America Cancer Biomarkers Market Outlook, By Prostate Cancer (2013-2022) ($MN)
68 North America Cancer Biomarkers Market Outlook, By Colorectal Cancer (2013-2022) ($MN)
69 North America Cancer Biomarkers Market Outlook, By Breast Cancer (2013-2022) ($MN)
70 North America Cancer Biomarkers Market Outlook, By Other Cancers (2013-2022) ($MN)
71 North America Cancer Biomarkers Market Outlook, By Profiling Technologies (2013-2022) ($MN)
72 North America Cancer Biomarkers Market Outlook, By Omics Technologies (2013-2022) ($MN)
73 North America Cancer Biomarkers Market Outlook, By Transcriptomics (2013-2022) ($MN)
74 North America Cancer Biomarkers Market Outlook, By Proteomics (2013-2022) ($MN)
75 North America Cancer Biomarkers Market Outlook, By Protein Microarray Technology (2013-2022) ($MN)
76 North America Cancer Biomarkers Market Outlook, By Peptide Array Technology (2013-2022) ($MN)
77 North America Cancer Biomarkers Market Outlook, By 2-D Gel Electrophoresis (2013-2022) ($MN)
78 North America Cancer Biomarkers Market Outlook, By Mass Spectrometry (2013-2022) ($MN)
79 North America Cancer Biomarkers Market Outlook, By Imaging Mass Spectrometry (2013-2022) ($MN)
80 North America Cancer Biomarkers Market Outlook, By Maldi Mass Spectrometry (2013-2022) ($MN)
81 North America Cancer Biomarkers Market Outlook, By Antibody Array Technology (2013-2022) ($MN)
82 North America Cancer Biomarkers Market Outlook, By Genomics (2013-2022) ($MN)
83 North America Cancer Biomarkers Market Outlook, By Microarrays (2013-2022) ($MN)
84 North America Cancer Biomarkers Market Outlook, By Next Generation Sequencing (NGS) (2013-2022) ($MN)
85 North America Cancer Biomarkers Market Outlook, By PCR (Polymer Chain Reaction) (2013-2022) ($MN)
86 North America Cancer Biomarkers Market Outlook, By Pharmacogenomics (2013-2022) ($MN)
87 North America Cancer Biomarkers Market Outlook, By Metabolomics (2013-2022) ($MN)
88 North America Cancer Biomarkers Market Outlook, By Bioinformatics (2013-2022) ($MN)
89 North America Cancer Biomarkers Market Outlook, By IVD multivariate index assays (2013-2022) ($MN)
90 North America Cancer Biomarkers Market Outlook, By Cytogenetics (2013-2022) ($MN)
91 North America Cancer Biomarkers Market Outlook, By DNA microarrays (2013-2022) ($MN)
92 North America Cancer Biomarkers Market Outlook, By Ish (In Situ Hybridization) (2013-2022) ($MN)
93 North America Cancer Biomarkers Market Outlook, By Immunoassays (2013-2022) ($MN)
94 North America Cancer Biomarkers Market Outlook, By Flow Cytometry (2013-2022) ($MN)
95 North America Cancer Biomarkers Market Outlook, By Elisa (2013-2022) ($MN)
96 North America Cancer Biomarkers Market Outlook, By Immunohistochemistry (IHC) (2013-2022) ($MN)
97 North America Cancer Biomarkers Market Outlook, By Imaging Technologies (2013-2022) ($MN)
98 North America Cancer Biomarkers Market Outlook, By Mammography (2013-2022) ($MN)
99 North America Cancer Biomarkers Market Outlook, By Ultrasound (2013-2022) ($MN)
100 North America Cancer Biomarkers Market Outlook, By Magnetic Resonance Imaging (MRI) (2013-2022) ($MN)
101 North America Cancer Biomarkers Market Outlook, By Computed Tomography (CT) (2013-2022) ($MN)
102 North America Cancer Biomarkers Market Outlook, By Positron Emission Tomography (PET) (2013-2022) ($MN)
103 North America Cancer Biomarkers Market Outlook, By Application (2013-2022) ($MN)
104 North America Cancer Biomarkers Market Outlook, By Risk Assessment (2013-2022) ($MN)
105 North America Cancer Biomarkers Market Outlook, By Drug Discovery and Development (2013-2022) ($MN)
106 North America Cancer Biomarkers Market Outlook, By Drug formulation (2013-2022) ($MN)
107 North America Cancer Biomarkers Market Outlook, By Diagnostics (2013-2022) ($MN)
108 North America Cancer Biomarkers Market Outlook, By Prognostics (2013-2022) ($MN)
109 North America Cancer Biomarkers Market Outlook, By Other Applications (2013-2022) ($MN)
110 North America Cancer Biomarkers Market Outlook, By Type (2013-2022) ($MN)
111 North America Cancer Biomarkers Market Outlook, By Genetic Biomarkers (2013-2022) ($MN)
112 North America Cancer Biomarkers Market Outlook, By Protein Biomarkers (2013-2022) ($MN)
113 North America Cancer Biomarkers Market Outlook, By Other Types (2013-2022) ($MN)
114 North America Cancer Biomarkers Market Outlook, By Carbohydrate biomarkers (2013-2022) ($MN)
115 North America Cancer Biomarkers Market Outlook, By Cell biomarkers (2013-2022) ($MN)
116 North America Cancer Biomarkers Market Outlook, By Viral biomarkers (2013-2022) ($MN)
117 Europe Cancer Biomarkers Market Outlook, By Country (2013-2022) ($MN)
118 Europe Cancer Biomarkers Market Outlook, By Service (2013-2022) ($MN)
119 Europe Cancer Biomarkers Market Outlook, By Biomakers validation and testing (2013-2022) ($MN)
120 Europe Cancer Biomarkers Market Outlook, By Sample preparation (2013-2022) ($MN)
121 Europe Cancer Biomarkers Market Outlook, By Assay developement (2013-2022) ($MN)
122 Europe Cancer Biomarkers Market Outlook, By Disease (2013-2022) ($MN)
123 Europe Cancer Biomarkers Market Outlook, By Lung Cancer (2013-2022) ($MN)
124 Europe Cancer Biomarkers Market Outlook, By Cervical Cancer (2013-2022) ($MN)
125 Europe Cancer Biomarkers Market Outlook, By Prostate Cancer (2013-2022) ($MN)
126 Europe Cancer Biomarkers Market Outlook, By Colorectal Cancer (2013-2022) ($MN)
127 Europe Cancer Biomarkers Market Outlook, By Breast Cancer (2013-2022) ($MN)
128 Europe Cancer Biomarkers Market Outlook, By Other Cancers (2013-2022) ($MN)
129 Europe Cancer Biomarkers Market Outlook, By Profiling Technologies (2013-2022) ($MN)
130 Europe Cancer Biomarkers Market Outlook, By Omics Technologies (2013-2022) ($MN)
131 Europe Cancer Biomarkers Market Outlook, By Transcriptomics (2013-2022) ($MN)
132 Europe Cancer Biomarkers Market Outlook, By Proteomics (2013-2022) ($MN)
133 Europe Cancer Biomarkers Market Outlook, By Protein Microarray Technology (2013-2022) ($MN)
134 Europe Cancer Biomarkers Market Outlook, By Peptide Array Technology (2013-2022) ($MN)
135 Europe Cancer Biomarkers Market Outlook, By 2-D Gel Electrophoresis (2013-2022) ($MN)
136 Europe Cancer Biomarkers Market Outlook, By Mass Spectrometry (2013-2022) ($MN)
137 Europe Cancer Biomarkers Market Outlook, By Imaging Mass Spectrometry (2013-2022) ($MN)
138 Europe Cancer Biomarkers Market Outlook, By Maldi Mass Spectrometry (2013-2022) ($MN)
139 Europe Cancer Biomarkers Market Outlook, By Antibody Array Technology (2013-2022) ($MN)
140 Europe Cancer Biomarkers Market Outlook, By Genomics (2013-2022) ($MN)
141 Europe Cancer Biomarkers Market Outlook, By Microarrays (2013-2022) ($MN)
142 Europe Cancer Biomarkers Market Outlook, By Next Generation Sequencing (NGS) (2013-2022) ($MN)
143 Europe Cancer Biomarkers Market Outlook, By PCR (Polymer Chain Reaction) (2013-2022) ($MN)
144 Europe Cancer Biomarkers Market Outlook, By Pharmacogenomics (2013-2022) ($MN)
145 Europe Cancer Biomarkers Market Outlook, By Metabolomics (2013-2022) ($MN)
146 Europe Cancer Biomarkers Market Outlook, By Bioinformatics (2013-2022) ($MN)
147 Europe Cancer Biomarkers Market Outlook, By IVD multivariate index assays (2013-2022) ($MN)
148 Europe Cancer Biomarkers Market Outlook, By Cytogenetics (2013-2022) ($MN)
149 Europe Cancer Biomarkers Market Outlook, By DNA microarrays (2013-2022) ($MN)
150 Europe Cancer Biomarkers Market Outlook, By Ish (In Situ Hybridization) (2013-2022) ($MN)
151 Europe Cancer Biomarkers Market Outlook, By Immunoassays (2013-2022) ($MN)
152 Europe Cancer Biomarkers Market Outlook, By Flow Cytometry (2013-2022) ($MN)
153 Europe Cancer Biomarkers Market Outlook, By Elisa (2013-2022) ($MN)
154 Europe Cancer Biomarkers Market Outlook, By Immunohistochemistry (IHC) (2013-2022) ($MN)
155 Europe Cancer Biomarkers Market Outlook, By Imaging Technologies (2013-2022) ($MN)
156 Europe Cancer Biomarkers Market Outlook, By Mammography (2013-2022) ($MN)
157 Europe Cancer Biomarkers Market Outlook, By Ultrasound (2013-2022) ($MN)
158 Europe Cancer Biomarkers Market Outlook, By Magnetic Resonance Imaging (MRI) (2013-2022) ($MN)
159 Europe Cancer Biomarkers Market Outlook, By Computed Tomography (CT) (2013-2022) ($MN)
160 Europe Cancer Biomarkers Market Outlook, By Positron Emission Tomography (PET) (2013-2022) ($MN)
161 Europe Cancer Biomarkers Market Outlook, By Application (2013-2022) ($MN)
162 Europe Cancer Biomarkers Market Outlook, By Risk Assessment (2013-2022) ($MN)
163 Europe Cancer Biomarkers Market Outlook, By Drug Discovery and Development (2013-2022) ($MN)
164 Europe Cancer Biomarkers Market Outlook, By Drug formulation (2013-2022) ($MN)
165 Europe Cancer Biomarkers Market Outlook, By Diagnostics (2013-2022) ($MN)
166 Europe Cancer Biomarkers Market Outlook, By Prognostics (2013-2022) ($MN)
167 Europe Cancer Biomarkers Market Outlook, By Other Applications (2013-2022) ($MN)
168 Europe Cancer Biomarkers Market Outlook, By Type (2013-2022) ($MN)
169 Europe Cancer Biomarkers Market Outlook, By Genetic Biomarkers (2013-2022) ($MN)
170 Europe Cancer Biomarkers Market Outlook, By Protein Biomarkers (2013-2022) ($MN)
171 Europe Cancer Biomarkers Market Outlook, By Other Types (2013-2022) ($MN)
172 Europe Cancer Biomarkers Market Outlook, By Carbohydrate biomarkers (2013-2022) ($MN)
173 Europe Cancer Biomarkers Market Outlook, By Cell biomarkers (2013-2022) ($MN)
174 Europe Cancer Biomarkers Market Outlook, By Viral biomarkers (2013-2022) ($MN)
175 Asia Pacific Cancer Biomarkers Market Outlook, By Country (2013-2022) ($MN)
176 Asia Pacific Cancer Biomarkers Market Outlook, By Service (2013-2022) ($MN)
177 Asia Pacific Cancer Biomarkers Market Outlook, By Biomakers validation and testing (2013-2022) ($MN)
178 Asia Pacific Cancer Biomarkers Market Outlook, By Sample preparation (2013-2022) ($MN)
179 Asia Pacific Cancer Biomarkers Market Outlook, By Assay developement (2013-2022) ($MN)
180 Asia Pacific Cancer Biomarkers Market Outlook, By Disease (2013-2022) ($MN)
181 Asia Pacific Cancer Biomarkers Market Outlook, By Lung Cancer (2013-2022) ($MN)
182 Asia Pacific Cancer Biomarkers Market Outlook, By Cervical Cancer (2013-2022) ($MN)
183 Asia Pacific Cancer Biomarkers Market Outlook, By Prostate Cancer (2013-2022) ($MN)
184 Asia Pacific Cancer Biomarkers Market Outlook, By Colorectal Cancer (2013-2022) ($MN)
185 Asia Pacific Cancer Biomarkers Market Outlook, By Breast Cancer (2013-2022) ($MN)
186 Asia Pacific Cancer Biomarkers Market Outlook, By Other Cancers (2013-2022) ($MN)
187 Asia Pacific Cancer Biomarkers Market Outlook, By Profiling Technologies (2013-2022) ($MN)
188 Asia Pacific Cancer Biomarkers Market Outlook, By Omics Technologies (2013-2022) ($MN)
189 Asia Pacific Cancer Biomarkers Market Outlook, By Transcriptomics (2013-2022) ($MN)
190 Asia Pacific Cancer Biomarkers Market Outlook, By Proteomics (2013-2022) ($MN)
191 Asia Pacific Cancer Biomarkers Market Outlook, By Protein Microarray Technology (2013-2022) ($MN)
192 Asia Pacific Cancer Biomarkers Market Outlook, By Peptide Array Technology (2013-2022) ($MN)
193 Asia Pacific Cancer Biomarkers Market Outlook, By 2-D Gel Electrophoresis (2013-2022) ($MN)
194 Asia Pacific Cancer Biomarkers Market Outlook, By Mass Spectrometry (2013-2022) ($MN)
195 Asia Pacific Cancer Biomarkers Market Outlook, By Imaging Mass Spectrometry (2013-2022) ($MN)
196 Asia Pacific Cancer Biomarkers Market Outlook, By Maldi Mass Spectrometry (2013-2022) ($MN)
197 Asia Pacific Cancer Biomarkers Market Outlook, By Antibody Array Technology (2013-2022) ($MN)
198 Asia Pacific Cancer Biomarkers Market Outlook, By Genomics (2013-2022) ($MN)
199 Asia Pacific Cancer Biomarkers Market Outlook, By Microarrays (2013-2022) ($MN)
200 Asia Pacific Cancer Biomarkers Market Outlook, By Next Generation Sequencing (NGS) (2013-2022) ($MN)
201 Asia Pacific Cancer Biomarkers Market Outlook, By PCR (Polymer Chain Reaction) (2013-2022) ($MN)
202 Asia Pacific Cancer Biomarkers Market Outlook, By Pharmacogenomics (2013-2022) ($MN)
203 Asia Pacific Cancer Biomarkers Market Outlook, By Metabolomics (2013-2022) ($MN)
204 Asia Pacific Cancer Biomarkers Market Outlook, By Bioinformatics (2013-2022) ($MN)
205 Asia Pacific Cancer Biomarkers Market Outlook, By IVD multivariate index assays (2013-2022) ($MN)
206 Asia Pacific Cancer Biomarkers Market Outlook, By Cytogenetics (2013-2022) ($MN)
207 Asia Pacific Cancer Biomarkers Market Outlook, By DNA microarrays (2013-2022) ($MN)
208 Asia Pacific Cancer Biomarkers Market Outlook, By Ish (In Situ Hybridization) (2013-2022) ($MN)
209 Asia Pacific Cancer Biomarkers Market Outlook, By Immunoassays (2013-2022) ($MN)
210 Asia Pacific Cancer Biomarkers Market Outlook, By Flow Cytometry (2013-2022) ($MN)
211 Asia Pacific Cancer Biomarkers Market Outlook, By Elisa (2013-2022) ($MN)
212 Asia Pacific Cancer Biomarkers Market Outlook, By Immunohistochemistry (IHC) (2013-2022) ($MN)
213 Asia Pacific Cancer Biomarkers Market Outlook, By Imaging Technologies (2013-2022) ($MN)
214 Asia Pacific Cancer Biomarkers Market Outlook, By Mammography (2013-2022) ($MN)
215 Asia Pacific Cancer Biomarkers Market Outlook, By Ultrasound (2013-2022) ($MN)
216 Asia Pacific Cancer Biomarkers Market Outlook, By Magnetic Resonance Imaging (MRI) (2013-2022) ($MN)
217 Asia Pacific Cancer Biomarkers Market Outlook, By Computed Tomography (CT) (2013-2022) ($MN)
218 Asia Pacific Cancer Biomarkers Market Outlook, By Positron Emission Tomography (PET) (2013-2022) ($MN)
219 Asia Pacific Cancer Biomarkers Market Outlook, By Application (2013-2022) ($MN)
220 Asia Pacific Cancer Biomarkers Market Outlook, By Risk Assessment (2013-2022) ($MN)
221 Asia Pacific Cancer Biomarkers Market Outlook, By Drug Discovery and Development (2013-2022) ($MN)
222 Asia Pacific Cancer Biomarkers Market Outlook, By Drug formulation (2013-2022) ($MN)
223 Asia Pacific Cancer Biomarkers Market Outlook, By Diagnostics (2013-2022) ($MN)
224 Asia Pacific Cancer Biomarkers Market Outlook, By Prognostics (2013-2022) ($MN)
225 Asia Pacific Cancer Biomarkers Market Outlook, By Other Applications (2013-2022) ($MN)
226 Asia Pacific Cancer Biomarkers Market Outlook, By Type (2013-2022) ($MN)
227 Asia Pacific Cancer Biomarkers Market Outlook, By Genetic Biomarkers (2013-2022) ($MN)
228 Asia Pacific Cancer Biomarkers Market Outlook, By Protein Biomarkers (2013-2022) ($MN)
229 Asia Pacific Cancer Biomarkers Market Outlook, By Other Types (2013-2022) ($MN)
230 Asia Pacific Cancer Biomarkers Market Outlook, By Carbohydrate biomarkers (2013-2022) ($MN)
231 Asia Pacific Cancer Biomarkers Market Outlook, By Cell biomarkers (2013-2022) ($MN)
232 Asia Pacific Cancer Biomarkers Market Outlook, By Viral biomarkers (2013-2022) ($MN)
233 RoW Cancer Biomarkers Market Outlook, By Country (2013-2022) ($MN)
234 RoW Cancer Biomarkers Market Outlook, By Service (2013-2022) ($MN)
235 RoW Cancer Biomarkers Market Outlook, By Biomakers validation and testing (2013-2022) ($MN)
236 RoW Cancer Biomarkers Market Outlook, By Sample preparation (2013-2022) ($MN)
237 RoW Cancer Biomarkers Market Outlook, By Assay developement (2013-2022) ($MN)
238 RoW Cancer Biomarkers Market Outlook, By Disease (2013-2022) ($MN)
239 RoW Cancer Biomarkers Market Outlook, By Lung Cancer (2013-2022) ($MN)
240 RoW Cancer Biomarkers Market Outlook, By Cervical Cancer (2013-2022) ($MN)
241 RoW Cancer Biomarkers Market Outlook, By Prostate Cancer (2013-2022) ($MN)
242 RoW Cancer Biomarkers Market Outlook, By Colorectal Cancer (2013-2022) ($MN)
243 RoW Cancer Biomarkers Market Outlook, By Breast Cancer (2013-2022) ($MN)
244 RoW Cancer Biomarkers Market Outlook, By Other Cancers (2013-2022) ($MN)
245 RoW Cancer Biomarkers Market Outlook, By Profiling Technologies (2013-2022) ($MN)
246 RoW Cancer Biomarkers Market Outlook, By Omics Technologies (2013-2022) ($MN)
247 RoW Cancer Biomarkers Market Outlook, By Transcriptomics (2013-2022) ($MN)
248 RoW Cancer Biomarkers Market Outlook, By Proteomics (2013-2022) ($MN)
249 RoW Cancer Biomarkers Market Outlook, By Protein Microarray Technology (2013-2022) ($MN)
250 RoW Cancer Biomarkers Market Outlook, By Peptide Array Technology (2013-2022) ($MN)
251 RoW Cancer Biomarkers Market Outlook, By 2-D Gel Electrophoresis (2013-2022) ($MN)
252 RoW Cancer Biomarkers Market Outlook, By Mass Spectrometry (2013-2022) ($MN)
253 RoW Cancer Biomarkers Market Outlook, By Imaging Mass Spectrometry (2013-2022) ($MN)
254 RoW Cancer Biomarkers Market Outlook, By Maldi Mass Spectrometry (2013-2022) ($MN)
255 RoW Cancer Biomarkers Market Outlook, By Antibody Array Technology (2013-2022) ($MN)
256 RoW Cancer Biomarkers Market Outlook, By Genomics (2013-2022) ($MN)
257 RoW Cancer Biomarkers Market Outlook, By Microarrays (2013-2022) ($MN)
258 RoW Cancer Biomarkers Market Outlook, By Next Generation Sequencing (NGS) (2013-2022) ($MN)
259 RoW Cancer Biomarkers Market Outlook, By PCR (Polymer Chain Reaction) (2013-2022) ($MN)
260 RoW Cancer Biomarkers Market Outlook, By Pharmacogenomics (2013-2022) ($MN)
261 RoW Cancer Biomarkers Market Outlook, By Metabolomics (2013-2022) ($MN)
262 RoW Cancer Biomarkers Market Outlook, By Bioinformatics (2013-2022) ($MN)
263 RoW Cancer Biomarkers Market Outlook, By IVD multivariate index assays (2013-2022) ($MN)
264 RoW Cancer Biomarkers Market Outlook, By Cytogenetics (2013-2022) ($MN)
265 RoW Cancer Biomarkers Market Outlook, By DNA microarrays (2013-2022) ($MN)
266 RoW Cancer Biomarkers Market Outlook, By Ish (In Situ Hybridization) (2013-2022) ($MN)
267 RoW Cancer Biomarkers Market Outlook, By Immunoassays (2013-2022) ($MN)
268 RoW Cancer Biomarkers Market Outlook, By Flow Cytometry (2013-2022) ($MN)
269 RoW Cancer Biomarkers Market Outlook, By Elisa (2013-2022) ($MN)
270 RoW Cancer Biomarkers Market Outlook, By Immunohistochemistry (IHC) (2013-2022) ($MN)
271 RoW Cancer Biomarkers Market Outlook, By Imaging Technologies (2013-2022) ($MN)
272 RoW Cancer Biomarkers Market Outlook, By Mammography (2013-2022) ($MN)
273 RoW Cancer Biomarkers Market Outlook, By Ultrasound (2013-2022) ($MN)
274 RoW Cancer Biomarkers Market Outlook, By Magnetic Resonance Imaging (MRI) (2013-2022) ($MN)
275 RoW Cancer Biomarkers Market Outlook, By Computed Tomography (CT) (2013-2022) ($MN)
276 RoW Cancer Biomarkers Market Outlook, By Positron Emission Tomography (PET) (2013-2022) ($MN)
277 RoW Cancer Biomarkers Market Outlook, By Application (2013-2022) ($MN)
278 RoW Cancer Biomarkers Market Outlook, By Risk Assessment (2013-2022) ($MN)
279 RoW Cancer Biomarkers Market Outlook, By Drug Discovery and Development (2013-2022) ($MN)
280 RoW Cancer Biomarkers Market Outlook, By Drug formulation (2013-2022) ($MN)
281 RoW Cancer Biomarkers Market Outlook, By Diagnostics (2013-2022) ($MN)
282 RoW Cancer Biomarkers Market Outlook, By Prognostics (2013-2022) ($MN)
283 RoW Cancer Biomarkers Market Outlook, By Other Applications (2013-2022) ($MN)
284 RoW Cancer Biomarkers Market Outlook, By Type (2013-2022) ($MN)
285 RoW Cancer Biomarkers Market Outlook, By Genetic Biomarkers (2013-2022) ($MN)
286 RoW Cancer Biomarkers Market Outlook, By Protein Biomarkers (2013-2022) ($MN)
287 RoW Cancer Biomarkers Market Outlook, By Other Types (2013-2022) ($MN)
288 RoW Cancer Biomarkers Market Outlook, By Carbohydrate biomarkers (2013-2022) ($MN)
289 RoW Cancer Biomarkers Market Outlook, By Cell biomarkers (2013-2022) ($MN)
290 RoW Cancer Biomarkers Market Outlook, By Viral biomarkers (2013-2022) ($MN)
1 Global Cancer Biomarkers Market Outlook, By Region (2013-2022) ($MN)
2 Global Cancer Biomarkers Market Outlook, By Service (2013-2022) ($MN)
3 Global Cancer Biomarkers Market Outlook, By Biomakers validation and testing (2013-2022) ($MN)
4 Global Cancer Biomarkers Market Outlook, By Sample preparation (2013-2022) ($MN)
5 Global Cancer Biomarkers Market Outlook, By Assay developement (2013-2022) ($MN)
6 Global Cancer Biomarkers Market Outlook, By Disease (2013-2022) ($MN)
7 Global Cancer Biomarkers Market Outlook, By Lung Cancer (2013-2022) ($MN)
8 Global Cancer Biomarkers Market Outlook, By Cervical Cancer (2013-2022) ($MN)
9 Global Cancer Biomarkers Market Outlook, By Prostate Cancer (2013-2022) ($MN)
10 Global Cancer Biomarkers Market Outlook, By Colorectal Cancer (2013-2022) ($MN)
11 Global Cancer Biomarkers Market Outlook, By Breast Cancer (2013-2022) ($MN)
12 Global Cancer Biomarkers Market Outlook, By Other Cancers (2013-2022) ($MN)
13 Global Cancer Biomarkers Market Outlook, By Profiling Technologies (2013-2022) ($MN)
14 Global Cancer Biomarkers Market Outlook, By Omics Technologies (2013-2022) ($MN)
15 Global Cancer Biomarkers Market Outlook, By Transcriptomics (2013-2022) ($MN)
16 Global Cancer Biomarkers Market Outlook, By Proteomics (2013-2022) ($MN)
17 Global Cancer Biomarkers Market Outlook, By Protein Microarray Technology (2013-2022) ($MN)
18 Global Cancer Biomarkers Market Outlook, By Peptide Array Technology (2013-2022) ($MN)
19 Global Cancer Biomarkers Market Outlook, By 2-D Gel Electrophoresis (2013-2022) ($MN)
20 Global Cancer Biomarkers Market Outlook, By Mass Spectrometry (2013-2022) ($MN)
21 Global Cancer Biomarkers Market Outlook, By Imaging Mass Spectrometry (2013-2022) ($MN)
22 Global Cancer Biomarkers Market Outlook, By Maldi Mass Spectrometry (2013-2022) ($MN)
23 Global Cancer Biomarkers Market Outlook, By Antibody Array Technology (2013-2022) ($MN)
24 Global Cancer Biomarkers Market Outlook, By Genomics (2013-2022) ($MN)
25 Global Cancer Biomarkers Market Outlook, By Microarrays (2013-2022) ($MN)
26 Global Cancer Biomarkers Market Outlook, By Next Generation Sequencing (NGS) (2013-2022) ($MN)
27 Global Cancer Biomarkers Market Outlook, By PCR (Polymer Chain Reaction) (2013-2022) ($MN)
28 Global Cancer Biomarkers Market Outlook, By Pharmacogenomics (2013-2022) ($MN)
29 Global Cancer Biomarkers Market Outlook, By Metabolomics (2013-2022) ($MN)
30 Global Cancer Biomarkers Market Outlook, By Bioinformatics (2013-2022) ($MN)
31 Global Cancer Biomarkers Market Outlook, By IVD multivariate index assays (2013-2022) ($MN)
32 Global Cancer Biomarkers Market Outlook, By Cytogenetics (2013-2022) ($MN)
33 Global Cancer Biomarkers Market Outlook, By DNA microarrays (2013-2022) ($MN)
34 Global Cancer Biomarkers Market Outlook, By Ish (In Situ Hybridization) (2013-2022) ($MN)
35 Global Cancer Biomarkers Market Outlook, By Immunoassays (2013-2022) ($MN)
36 Global Cancer Biomarkers Market Outlook, By Flow Cytometry (2013-2022) ($MN)
37 Global Cancer Biomarkers Market Outlook, By Elisa (2013-2022) ($MN)
38 Global Cancer Biomarkers Market Outlook, By Immunohistochemistry (IHC) (2013-2022) ($MN)
39 Global Cancer Biomarkers Market Outlook, By Imaging Technologies (2013-2022) ($MN)
40 Global Cancer Biomarkers Market Outlook, By Mammography (2013-2022) ($MN)
41 Global Cancer Biomarkers Market Outlook, By Ultrasound (2013-2022) ($MN)
42 Global Cancer Biomarkers Market Outlook, By Magnetic Resonance Imaging (MRI) (2013-2022) ($MN)
43 Global Cancer Biomarkers Market Outlook, By Computed Tomography (CT) (2013-2022) ($MN)
44 Global Cancer Biomarkers Market Outlook, By Positron Emission Tomography (PET) (2013-2022) ($MN)
45 Global Cancer Biomarkers Market Outlook, By Application (2013-2022) ($MN)
46 Global Cancer Biomarkers Market Outlook, By Risk Assessment (2013-2022) ($MN)
47 Global Cancer Biomarkers Market Outlook, By Drug Discovery and Development (2013-2022) ($MN)
48 Global Cancer Biomarkers Market Outlook, By Drug formulation (2013-2022) ($MN)
49 Global Cancer Biomarkers Market Outlook, By Diagnostics (2013-2022) ($MN)
50 Global Cancer Biomarkers Market Outlook, By Prognostics (2013-2022) ($MN)
51 Global Cancer Biomarkers Market Outlook, By Other Applications (2013-2022) ($MN)
52 Global Cancer Biomarkers Market Outlook, By Type (2013-2022) ($MN)
53 Global Cancer Biomarkers Market Outlook, By Genetic Biomarkers (2013-2022) ($MN)
54 Global Cancer Biomarkers Market Outlook, By Protein Biomarkers (2013-2022) ($MN)
55 Global Cancer Biomarkers Market Outlook, By Other Types (2013-2022) ($MN)
56 Global Cancer Biomarkers Market Outlook, By Carbohydrate biomarkers (2013-2022) ($MN)
57 Global Cancer Biomarkers Market Outlook, By Cell biomarkers (2013-2022) ($MN)
58 Global Cancer Biomarkers Market Outlook, By Viral biomarkers (2013-2022) ($MN)
59 North America Cancer Biomarkers Market Outlook, By Country (2013-2022) ($MN)
60 North America Cancer Biomarkers Market Outlook, By Service (2013-2022) ($MN)
61 North America Cancer Biomarkers Market Outlook, By Biomakers validation and testing (2013-2022) ($MN)
62 North America Cancer Biomarkers Market Outlook, By Sample preparation (2013-2022) ($MN)
63 North America Cancer Biomarkers Market Outlook, By Assay developement (2013-2022) ($MN)
64 North America Cancer Biomarkers Market Outlook, By Disease (2013-2022) ($MN)
65 North America Cancer Biomarkers Market Outlook, By Lung Cancer (2013-2022) ($MN)
66 North America Cancer Biomarkers Market Outlook, By Cervical Cancer (2013-2022) ($MN)
67 North America Cancer Biomarkers Market Outlook, By Prostate Cancer (2013-2022) ($MN)
68 North America Cancer Biomarkers Market Outlook, By Colorectal Cancer (2013-2022) ($MN)
69 North America Cancer Biomarkers Market Outlook, By Breast Cancer (2013-2022) ($MN)
70 North America Cancer Biomarkers Market Outlook, By Other Cancers (2013-2022) ($MN)
71 North America Cancer Biomarkers Market Outlook, By Profiling Technologies (2013-2022) ($MN)
72 North America Cancer Biomarkers Market Outlook, By Omics Technologies (2013-2022) ($MN)
73 North America Cancer Biomarkers Market Outlook, By Transcriptomics (2013-2022) ($MN)
74 North America Cancer Biomarkers Market Outlook, By Proteomics (2013-2022) ($MN)
75 North America Cancer Biomarkers Market Outlook, By Protein Microarray Technology (2013-2022) ($MN)
76 North America Cancer Biomarkers Market Outlook, By Peptide Array Technology (2013-2022) ($MN)
77 North America Cancer Biomarkers Market Outlook, By 2-D Gel Electrophoresis (2013-2022) ($MN)
78 North America Cancer Biomarkers Market Outlook, By Mass Spectrometry (2013-2022) ($MN)
79 North America Cancer Biomarkers Market Outlook, By Imaging Mass Spectrometry (2013-2022) ($MN)
80 North America Cancer Biomarkers Market Outlook, By Maldi Mass Spectrometry (2013-2022) ($MN)
81 North America Cancer Biomarkers Market Outlook, By Antibody Array Technology (2013-2022) ($MN)
82 North America Cancer Biomarkers Market Outlook, By Genomics (2013-2022) ($MN)
83 North America Cancer Biomarkers Market Outlook, By Microarrays (2013-2022) ($MN)
84 North America Cancer Biomarkers Market Outlook, By Next Generation Sequencing (NGS) (2013-2022) ($MN)
85 North America Cancer Biomarkers Market Outlook, By PCR (Polymer Chain Reaction) (2013-2022) ($MN)
86 North America Cancer Biomarkers Market Outlook, By Pharmacogenomics (2013-2022) ($MN)
87 North America Cancer Biomarkers Market Outlook, By Metabolomics (2013-2022) ($MN)
88 North America Cancer Biomarkers Market Outlook, By Bioinformatics (2013-2022) ($MN)
89 North America Cancer Biomarkers Market Outlook, By IVD multivariate index assays (2013-2022) ($MN)
90 North America Cancer Biomarkers Market Outlook, By Cytogenetics (2013-2022) ($MN)
91 North America Cancer Biomarkers Market Outlook, By DNA microarrays (2013-2022) ($MN)
92 North America Cancer Biomarkers Market Outlook, By Ish (In Situ Hybridization) (2013-2022) ($MN)
93 North America Cancer Biomarkers Market Outlook, By Immunoassays (2013-2022) ($MN)
94 North America Cancer Biomarkers Market Outlook, By Flow Cytometry (2013-2022) ($MN)
95 North America Cancer Biomarkers Market Outlook, By Elisa (2013-2022) ($MN)
96 North America Cancer Biomarkers Market Outlook, By Immunohistochemistry (IHC) (2013-2022) ($MN)
97 North America Cancer Biomarkers Market Outlook, By Imaging Technologies (2013-2022) ($MN)
98 North America Cancer Biomarkers Market Outlook, By Mammography (2013-2022) ($MN)
99 North America Cancer Biomarkers Market Outlook, By Ultrasound (2013-2022) ($MN)
100 North America Cancer Biomarkers Market Outlook, By Magnetic Resonance Imaging (MRI) (2013-2022) ($MN)
101 North America Cancer Biomarkers Market Outlook, By Computed Tomography (CT) (2013-2022) ($MN)
102 North America Cancer Biomarkers Market Outlook, By Positron Emission Tomography (PET) (2013-2022) ($MN)
103 North America Cancer Biomarkers Market Outlook, By Application (2013-2022) ($MN)
104 North America Cancer Biomarkers Market Outlook, By Risk Assessment (2013-2022) ($MN)
105 North America Cancer Biomarkers Market Outlook, By Drug Discovery and Development (2013-2022) ($MN)
106 North America Cancer Biomarkers Market Outlook, By Drug formulation (2013-2022) ($MN)
107 North America Cancer Biomarkers Market Outlook, By Diagnostics (2013-2022) ($MN)
108 North America Cancer Biomarkers Market Outlook, By Prognostics (2013-2022) ($MN)
109 North America Cancer Biomarkers Market Outlook, By Other Applications (2013-2022) ($MN)
110 North America Cancer Biomarkers Market Outlook, By Type (2013-2022) ($MN)
111 North America Cancer Biomarkers Market Outlook, By Genetic Biomarkers (2013-2022) ($MN)
112 North America Cancer Biomarkers Market Outlook, By Protein Biomarkers (2013-2022) ($MN)
113 North America Cancer Biomarkers Market Outlook, By Other Types (2013-2022) ($MN)
114 North America Cancer Biomarkers Market Outlook, By Carbohydrate biomarkers (2013-2022) ($MN)
115 North America Cancer Biomarkers Market Outlook, By Cell biomarkers (2013-2022) ($MN)
116 North America Cancer Biomarkers Market Outlook, By Viral biomarkers (2013-2022) ($MN)
117 Europe Cancer Biomarkers Market Outlook, By Country (2013-2022) ($MN)
118 Europe Cancer Biomarkers Market Outlook, By Service (2013-2022) ($MN)
119 Europe Cancer Biomarkers Market Outlook, By Biomakers validation and testing (2013-2022) ($MN)
120 Europe Cancer Biomarkers Market Outlook, By Sample preparation (2013-2022) ($MN)
121 Europe Cancer Biomarkers Market Outlook, By Assay developement (2013-2022) ($MN)
122 Europe Cancer Biomarkers Market Outlook, By Disease (2013-2022) ($MN)
123 Europe Cancer Biomarkers Market Outlook, By Lung Cancer (2013-2022) ($MN)
124 Europe Cancer Biomarkers Market Outlook, By Cervical Cancer (2013-2022) ($MN)
125 Europe Cancer Biomarkers Market Outlook, By Prostate Cancer (2013-2022) ($MN)
126 Europe Cancer Biomarkers Market Outlook, By Colorectal Cancer (2013-2022) ($MN)
127 Europe Cancer Biomarkers Market Outlook, By Breast Cancer (2013-2022) ($MN)
128 Europe Cancer Biomarkers Market Outlook, By Other Cancers (2013-2022) ($MN)
129 Europe Cancer Biomarkers Market Outlook, By Profiling Technologies (2013-2022) ($MN)
130 Europe Cancer Biomarkers Market Outlook, By Omics Technologies (2013-2022) ($MN)
131 Europe Cancer Biomarkers Market Outlook, By Transcriptomics (2013-2022) ($MN)
132 Europe Cancer Biomarkers Market Outlook, By Proteomics (2013-2022) ($MN)
133 Europe Cancer Biomarkers Market Outlook, By Protein Microarray Technology (2013-2022) ($MN)
134 Europe Cancer Biomarkers Market Outlook, By Peptide Array Technology (2013-2022) ($MN)
135 Europe Cancer Biomarkers Market Outlook, By 2-D Gel Electrophoresis (2013-2022) ($MN)
136 Europe Cancer Biomarkers Market Outlook, By Mass Spectrometry (2013-2022) ($MN)
137 Europe Cancer Biomarkers Market Outlook, By Imaging Mass Spectrometry (2013-2022) ($MN)
138 Europe Cancer Biomarkers Market Outlook, By Maldi Mass Spectrometry (2013-2022) ($MN)
139 Europe Cancer Biomarkers Market Outlook, By Antibody Array Technology (2013-2022) ($MN)
140 Europe Cancer Biomarkers Market Outlook, By Genomics (2013-2022) ($MN)
141 Europe Cancer Biomarkers Market Outlook, By Microarrays (2013-2022) ($MN)
142 Europe Cancer Biomarkers Market Outlook, By Next Generation Sequencing (NGS) (2013-2022) ($MN)
143 Europe Cancer Biomarkers Market Outlook, By PCR (Polymer Chain Reaction) (2013-2022) ($MN)
144 Europe Cancer Biomarkers Market Outlook, By Pharmacogenomics (2013-2022) ($MN)
145 Europe Cancer Biomarkers Market Outlook, By Metabolomics (2013-2022) ($MN)
146 Europe Cancer Biomarkers Market Outlook, By Bioinformatics (2013-2022) ($MN)
147 Europe Cancer Biomarkers Market Outlook, By IVD multivariate index assays (2013-2022) ($MN)
148 Europe Cancer Biomarkers Market Outlook, By Cytogenetics (2013-2022) ($MN)
149 Europe Cancer Biomarkers Market Outlook, By DNA microarrays (2013-2022) ($MN)
150 Europe Cancer Biomarkers Market Outlook, By Ish (In Situ Hybridization) (2013-2022) ($MN)
151 Europe Cancer Biomarkers Market Outlook, By Immunoassays (2013-2022) ($MN)
152 Europe Cancer Biomarkers Market Outlook, By Flow Cytometry (2013-2022) ($MN)
153 Europe Cancer Biomarkers Market Outlook, By Elisa (2013-2022) ($MN)
154 Europe Cancer Biomarkers Market Outlook, By Immunohistochemistry (IHC) (2013-2022) ($MN)
155 Europe Cancer Biomarkers Market Outlook, By Imaging Technologies (2013-2022) ($MN)
156 Europe Cancer Biomarkers Market Outlook, By Mammography (2013-2022) ($MN)
157 Europe Cancer Biomarkers Market Outlook, By Ultrasound (2013-2022) ($MN)
158 Europe Cancer Biomarkers Market Outlook, By Magnetic Resonance Imaging (MRI) (2013-2022) ($MN)
159 Europe Cancer Biomarkers Market Outlook, By Computed Tomography (CT) (2013-2022) ($MN)
160 Europe Cancer Biomarkers Market Outlook, By Positron Emission Tomography (PET) (2013-2022) ($MN)
161 Europe Cancer Biomarkers Market Outlook, By Application (2013-2022) ($MN)
162 Europe Cancer Biomarkers Market Outlook, By Risk Assessment (2013-2022) ($MN)
163 Europe Cancer Biomarkers Market Outlook, By Drug Discovery and Development (2013-2022) ($MN)
164 Europe Cancer Biomarkers Market Outlook, By Drug formulation (2013-2022) ($MN)
165 Europe Cancer Biomarkers Market Outlook, By Diagnostics (2013-2022) ($MN)
166 Europe Cancer Biomarkers Market Outlook, By Prognostics (2013-2022) ($MN)
167 Europe Cancer Biomarkers Market Outlook, By Other Applications (2013-2022) ($MN)
168 Europe Cancer Biomarkers Market Outlook, By Type (2013-2022) ($MN)
169 Europe Cancer Biomarkers Market Outlook, By Genetic Biomarkers (2013-2022) ($MN)
170 Europe Cancer Biomarkers Market Outlook, By Protein Biomarkers (2013-2022) ($MN)
171 Europe Cancer Biomarkers Market Outlook, By Other Types (2013-2022) ($MN)
172 Europe Cancer Biomarkers Market Outlook, By Carbohydrate biomarkers (2013-2022) ($MN)
173 Europe Cancer Biomarkers Market Outlook, By Cell biomarkers (2013-2022) ($MN)
174 Europe Cancer Biomarkers Market Outlook, By Viral biomarkers (2013-2022) ($MN)
175 Asia Pacific Cancer Biomarkers Market Outlook, By Country (2013-2022) ($MN)
176 Asia Pacific Cancer Biomarkers Market Outlook, By Service (2013-2022) ($MN)
177 Asia Pacific Cancer Biomarkers Market Outlook, By Biomakers validation and testing (2013-2022) ($MN)
178 Asia Pacific Cancer Biomarkers Market Outlook, By Sample preparation (2013-2022) ($MN)
179 Asia Pacific Cancer Biomarkers Market Outlook, By Assay developement (2013-2022) ($MN)
180 Asia Pacific Cancer Biomarkers Market Outlook, By Disease (2013-2022) ($MN)
181 Asia Pacific Cancer Biomarkers Market Outlook, By Lung Cancer (2013-2022) ($MN)
182 Asia Pacific Cancer Biomarkers Market Outlook, By Cervical Cancer (2013-2022) ($MN)
183 Asia Pacific Cancer Biomarkers Market Outlook, By Prostate Cancer (2013-2022) ($MN)
184 Asia Pacific Cancer Biomarkers Market Outlook, By Colorectal Cancer (2013-2022) ($MN)
185 Asia Pacific Cancer Biomarkers Market Outlook, By Breast Cancer (2013-2022) ($MN)
186 Asia Pacific Cancer Biomarkers Market Outlook, By Other Cancers (2013-2022) ($MN)
187 Asia Pacific Cancer Biomarkers Market Outlook, By Profiling Technologies (2013-2022) ($MN)
188 Asia Pacific Cancer Biomarkers Market Outlook, By Omics Technologies (2013-2022) ($MN)
189 Asia Pacific Cancer Biomarkers Market Outlook, By Transcriptomics (2013-2022) ($MN)
190 Asia Pacific Cancer Biomarkers Market Outlook, By Proteomics (2013-2022) ($MN)
191 Asia Pacific Cancer Biomarkers Market Outlook, By Protein Microarray Technology (2013-2022) ($MN)
192 Asia Pacific Cancer Biomarkers Market Outlook, By Peptide Array Technology (2013-2022) ($MN)
193 Asia Pacific Cancer Biomarkers Market Outlook, By 2-D Gel Electrophoresis (2013-2022) ($MN)
194 Asia Pacific Cancer Biomarkers Market Outlook, By Mass Spectrometry (2013-2022) ($MN)
195 Asia Pacific Cancer Biomarkers Market Outlook, By Imaging Mass Spectrometry (2013-2022) ($MN)
196 Asia Pacific Cancer Biomarkers Market Outlook, By Maldi Mass Spectrometry (2013-2022) ($MN)
197 Asia Pacific Cancer Biomarkers Market Outlook, By Antibody Array Technology (2013-2022) ($MN)
198 Asia Pacific Cancer Biomarkers Market Outlook, By Genomics (2013-2022) ($MN)
199 Asia Pacific Cancer Biomarkers Market Outlook, By Microarrays (2013-2022) ($MN)
200 Asia Pacific Cancer Biomarkers Market Outlook, By Next Generation Sequencing (NGS) (2013-2022) ($MN)
201 Asia Pacific Cancer Biomarkers Market Outlook, By PCR (Polymer Chain Reaction) (2013-2022) ($MN)
202 Asia Pacific Cancer Biomarkers Market Outlook, By Pharmacogenomics (2013-2022) ($MN)
203 Asia Pacific Cancer Biomarkers Market Outlook, By Metabolomics (2013-2022) ($MN)
204 Asia Pacific Cancer Biomarkers Market Outlook, By Bioinformatics (2013-2022) ($MN)
205 Asia Pacific Cancer Biomarkers Market Outlook, By IVD multivariate index assays (2013-2022) ($MN)
206 Asia Pacific Cancer Biomarkers Market Outlook, By Cytogenetics (2013-2022) ($MN)
207 Asia Pacific Cancer Biomarkers Market Outlook, By DNA microarrays (2013-2022) ($MN)
208 Asia Pacific Cancer Biomarkers Market Outlook, By Ish (In Situ Hybridization) (2013-2022) ($MN)
209 Asia Pacific Cancer Biomarkers Market Outlook, By Immunoassays (2013-2022) ($MN)
210 Asia Pacific Cancer Biomarkers Market Outlook, By Flow Cytometry (2013-2022) ($MN)
211 Asia Pacific Cancer Biomarkers Market Outlook, By Elisa (2013-2022) ($MN)
212 Asia Pacific Cancer Biomarkers Market Outlook, By Immunohistochemistry (IHC) (2013-2022) ($MN)
213 Asia Pacific Cancer Biomarkers Market Outlook, By Imaging Technologies (2013-2022) ($MN)
214 Asia Pacific Cancer Biomarkers Market Outlook, By Mammography (2013-2022) ($MN)
215 Asia Pacific Cancer Biomarkers Market Outlook, By Ultrasound (2013-2022) ($MN)
216 Asia Pacific Cancer Biomarkers Market Outlook, By Magnetic Resonance Imaging (MRI) (2013-2022) ($MN)
217 Asia Pacific Cancer Biomarkers Market Outlook, By Computed Tomography (CT) (2013-2022) ($MN)
218 Asia Pacific Cancer Biomarkers Market Outlook, By Positron Emission Tomography (PET) (2013-2022) ($MN)
219 Asia Pacific Cancer Biomarkers Market Outlook, By Application (2013-2022) ($MN)
220 Asia Pacific Cancer Biomarkers Market Outlook, By Risk Assessment (2013-2022) ($MN)
221 Asia Pacific Cancer Biomarkers Market Outlook, By Drug Discovery and Development (2013-2022) ($MN)
222 Asia Pacific Cancer Biomarkers Market Outlook, By Drug formulation (2013-2022) ($MN)
223 Asia Pacific Cancer Biomarkers Market Outlook, By Diagnostics (2013-2022) ($MN)
224 Asia Pacific Cancer Biomarkers Market Outlook, By Prognostics (2013-2022) ($MN)
225 Asia Pacific Cancer Biomarkers Market Outlook, By Other Applications (2013-2022) ($MN)
226 Asia Pacific Cancer Biomarkers Market Outlook, By Type (2013-2022) ($MN)
227 Asia Pacific Cancer Biomarkers Market Outlook, By Genetic Biomarkers (2013-2022) ($MN)
228 Asia Pacific Cancer Biomarkers Market Outlook, By Protein Biomarkers (2013-2022) ($MN)
229 Asia Pacific Cancer Biomarkers Market Outlook, By Other Types (2013-2022) ($MN)
230 Asia Pacific Cancer Biomarkers Market Outlook, By Carbohydrate biomarkers (2013-2022) ($MN)
231 Asia Pacific Cancer Biomarkers Market Outlook, By Cell biomarkers (2013-2022) ($MN)
232 Asia Pacific Cancer Biomarkers Market Outlook, By Viral biomarkers (2013-2022) ($MN)
233 RoW Cancer Biomarkers Market Outlook, By Country (2013-2022) ($MN)
234 RoW Cancer Biomarkers Market Outlook, By Service (2013-2022) ($MN)
235 RoW Cancer Biomarkers Market Outlook, By Biomakers validation and testing (2013-2022) ($MN)
236 RoW Cancer Biomarkers Market Outlook, By Sample preparation (2013-2022) ($MN)
237 RoW Cancer Biomarkers Market Outlook, By Assay developement (2013-2022) ($MN)
238 RoW Cancer Biomarkers Market Outlook, By Disease (2013-2022) ($MN)
239 RoW Cancer Biomarkers Market Outlook, By Lung Cancer (2013-2022) ($MN)
240 RoW Cancer Biomarkers Market Outlook, By Cervical Cancer (2013-2022) ($MN)
241 RoW Cancer Biomarkers Market Outlook, By Prostate Cancer (2013-2022) ($MN)
242 RoW Cancer Biomarkers Market Outlook, By Colorectal Cancer (2013-2022) ($MN)
243 RoW Cancer Biomarkers Market Outlook, By Breast Cancer (2013-2022) ($MN)
244 RoW Cancer Biomarkers Market Outlook, By Other Cancers (2013-2022) ($MN)
245 RoW Cancer Biomarkers Market Outlook, By Profiling Technologies (2013-2022) ($MN)
246 RoW Cancer Biomarkers Market Outlook, By Omics Technologies (2013-2022) ($MN)
247 RoW Cancer Biomarkers Market Outlook, By Transcriptomics (2013-2022) ($MN)
248 RoW Cancer Biomarkers Market Outlook, By Proteomics (2013-2022) ($MN)
249 RoW Cancer Biomarkers Market Outlook, By Protein Microarray Technology (2013-2022) ($MN)
250 RoW Cancer Biomarkers Market Outlook, By Peptide Array Technology (2013-2022) ($MN)
251 RoW Cancer Biomarkers Market Outlook, By 2-D Gel Electrophoresis (2013-2022) ($MN)
252 RoW Cancer Biomarkers Market Outlook, By Mass Spectrometry (2013-2022) ($MN)
253 RoW Cancer Biomarkers Market Outlook, By Imaging Mass Spectrometry (2013-2022) ($MN)
254 RoW Cancer Biomarkers Market Outlook, By Maldi Mass Spectrometry (2013-2022) ($MN)
255 RoW Cancer Biomarkers Market Outlook, By Antibody Array Technology (2013-2022) ($MN)
256 RoW Cancer Biomarkers Market Outlook, By Genomics (2013-2022) ($MN)
257 RoW Cancer Biomarkers Market Outlook, By Microarrays (2013-2022) ($MN)
258 RoW Cancer Biomarkers Market Outlook, By Next Generation Sequencing (NGS) (2013-2022) ($MN)
259 RoW Cancer Biomarkers Market Outlook, By PCR (Polymer Chain Reaction) (2013-2022) ($MN)
260 RoW Cancer Biomarkers Market Outlook, By Pharmacogenomics (2013-2022) ($MN)
261 RoW Cancer Biomarkers Market Outlook, By Metabolomics (2013-2022) ($MN)
262 RoW Cancer Biomarkers Market Outlook, By Bioinformatics (2013-2022) ($MN)
263 RoW Cancer Biomarkers Market Outlook, By IVD multivariate index assays (2013-2022) ($MN)
264 RoW Cancer Biomarkers Market Outlook, By Cytogenetics (2013-2022) ($MN)
265 RoW Cancer Biomarkers Market Outlook, By DNA microarrays (2013-2022) ($MN)
266 RoW Cancer Biomarkers Market Outlook, By Ish (In Situ Hybridization) (2013-2022) ($MN)
267 RoW Cancer Biomarkers Market Outlook, By Immunoassays (2013-2022) ($MN)
268 RoW Cancer Biomarkers Market Outlook, By Flow Cytometry (2013-2022) ($MN)
269 RoW Cancer Biomarkers Market Outlook, By Elisa (2013-2022) ($MN)
270 RoW Cancer Biomarkers Market Outlook, By Immunohistochemistry (IHC) (2013-2022) ($MN)
271 RoW Cancer Biomarkers Market Outlook, By Imaging Technologies (2013-2022) ($MN)
272 RoW Cancer Biomarkers Market Outlook, By Mammography (2013-2022) ($MN)
273 RoW Cancer Biomarkers Market Outlook, By Ultrasound (2013-2022) ($MN)
274 RoW Cancer Biomarkers Market Outlook, By Magnetic Resonance Imaging (MRI) (2013-2022) ($MN)
275 RoW Cancer Biomarkers Market Outlook, By Computed Tomography (CT) (2013-2022) ($MN)
276 RoW Cancer Biomarkers Market Outlook, By Positron Emission Tomography (PET) (2013-2022) ($MN)
277 RoW Cancer Biomarkers Market Outlook, By Application (2013-2022) ($MN)
278 RoW Cancer Biomarkers Market Outlook, By Risk Assessment (2013-2022) ($MN)
279 RoW Cancer Biomarkers Market Outlook, By Drug Discovery and Development (2013-2022) ($MN)
280 RoW Cancer Biomarkers Market Outlook, By Drug formulation (2013-2022) ($MN)
281 RoW Cancer Biomarkers Market Outlook, By Diagnostics (2013-2022) ($MN)
282 RoW Cancer Biomarkers Market Outlook, By Prognostics (2013-2022) ($MN)
283 RoW Cancer Biomarkers Market Outlook, By Other Applications (2013-2022) ($MN)
284 RoW Cancer Biomarkers Market Outlook, By Type (2013-2022) ($MN)
285 RoW Cancer Biomarkers Market Outlook, By Genetic Biomarkers (2013-2022) ($MN)
286 RoW Cancer Biomarkers Market Outlook, By Protein Biomarkers (2013-2022) ($MN)
287 RoW Cancer Biomarkers Market Outlook, By Other Types (2013-2022) ($MN)
288 RoW Cancer Biomarkers Market Outlook, By Carbohydrate biomarkers (2013-2022) ($MN)
289 RoW Cancer Biomarkers Market Outlook, By Cell biomarkers (2013-2022) ($MN)
290 RoW Cancer Biomarkers Market Outlook, By Viral biomarkers (2013-2022) ($MN)
